Target intelligence / Profile preview

Ribosomal protein L39 pseudogene 14 (RPL39P14)

Target: RPL39P14
Molecular classification: Other (Pseudogene)

Overview

RPL39P14 is a pseudogene, meaning it is a genomic DNA sequence similar to the ribosomal protein L39 gene but lacking the ability to encode a functional protein. It is catalogued in genomic databases (HGNC, NCBI, Ensembl) exclusively as a pseudogene. Such pseudogenes sometimes serve as historical markers of gene duplication events, but they do not produce functional products and have no established role in therapeutic targeting or disease, nor any protein-level biological or pharmacological relevance[4][8].

Other names: Ribosomal protein L39 pseudogene 14RPL39P14HGNC:36609NCBI Gene:100132127Ensembl:ENSG00000224463

Beyond the preview

Go deeper on Ribosomal protein L39 pseudogene 14 (RPL39P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L39 pseudogene 14 (RPL39P14).

Explore the full profile